Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Malaysia Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20043
20053
20061
20071
20085
20097
201017
20115
20128
20135
20142
20152
20161
20174
20195
20203
20211
20221
20232
20241
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Terminated13
Recruiting6
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S28
Boehringer Ingelheim12
AstraZeneca11
Janssen Research & Development, LLC8
Hoffmann-La Roche5
Sanofi5
Takeda5
Bayer2
National University of Malaysia2
Phenomix2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 285
Diabetes Mellitus24
Cardiovascular Diseases4
Diabetic Nephropathies3
Hyperglycemia3
Kidney Diseases2
Obesity2
Overweight2
Renal Insufficiency2
Renal Insufficiency, Chronic2

Trials

Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.